Mark Falkowski
Chief Executive Officer
oncology
Pyrexar Medical
Japan
Biography
Mark Falkowski provides strong executive leadership with an enviable and distinguished history of success in building strong organizations for prominent medical device companies. His no-nonsense approach includes creating powerful and focused teams, organized to achieve key objectives and maximize value for all shareholders. Mr. Falkowski has demonstrated his ability to evaluate, streamline, re-structure and re-energize companies while positioning them for maximum performance. Key Objectives: • Raised six Million dollars to start Pyrexar Medical Inc. April 2015. • Smooth new organization start-up and transition for design, production, customer service and administrative teams. • Raise awareness of Pyrexar Medical Hyperthermia clinical capabilities among mainstream oncology practitioners. • Champion the creation of innovative new thermal cancer treatment technologies, focused on highest priority needs of clinical practitioners. • Continue to develop Pyrexar Medical Hyperthermia products that will meet the needs of physicians and patients to kill cancer.
Research Interest
surgery